Drug Profile


Alternative Names: BENSPM; CI 1006; DE 333; DENSPM; N-N-diethylnorspermine

Latest Information Update: 20 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genzyme Corporation
  • Developer Genzyme Corporation; Nippon Kayaku; University of Toronto
  • Class Antineoplastics; Polyamines; Small molecules
  • Mechanism of Action Adenosylmethionine decarboxylase inhibitors; Ornithine decarboxylase inhibitors; Spermidine-spermine N1-acetyltransferase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver cancer
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Alzheimer's disease; Cancer; Liver cancer; Psoriasis

Most Recent Events

  • 23 Aug 2007 Discontinued - Phase-I for Cancer in Japan (IV)
  • 28 Apr 2006 This compound is still in active development for Liver cancer
  • 30 Jul 2004 Phase-I/II clinical trials in Liver cancer in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top